Beyond forgetfulness: Why we must act on Alzheimer’s disease now

In the face of an increasingly aging population, today’s reality reveals a harsh truth: health systems…

Reigniting vaccine leadership in the EU

In an era marked by rapid technological advancements and fierce global competition in health, the European…

Letters show Sask. Party turned down $2 million donation for Estevan MRI | Globalnews.ca

NDP leader Carla Beck tore down the Saskatchewan Party government on Tuesday, saying it denied a…

Severe asthma — breaking the cycle of inadequate care

Asthma has long lagged behind other inflammatory conditions in terms of political attention and progress on…

Labs: the (overlooked) building block of Universal Health Coverage

Hepatitis C (HCV) — a potentially life-threatening virus that infects 1.5 million new people around the…

‘Waiting well beyond the national standard’: N.S. MRI backlog sees wait-list up to a year – Halifax | Globalnews.ca

Thousands of people across Nova Scotia are on the wait-list for magnetic resonance imaging (MRI) and,…

The Joint Procurement Agreement: driving EU health solidarity

Don’t get sick in Greece! Islands jammed with tourists, but critically short of medics

Press play to listen to this article Voiced by artificial intelligence. ATHENS — Greece’s idyllic islands…

A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare

Biogen, Eli Lilly drugs to expand imaging market for companies in diagnostics sector.

Biogen to Cut Roughly 11% of Workforce to Focus on Big-Return Drugs

The biotech company cited the launch of Alzheimer’s drug Lekembi as part of its new focus…